![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1616720
ÄÍÆä·Ñ ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2024-2032³â)Kaempferol Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032 |
ÄÍÆä·Ñ ¼¼°è ½ÃÀåÀº 2023³â 62¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2024-2032³â µ¿¾È ¿¬Æò±Õ 3.3% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ÀǾàǰ, ½ºÅ²Äɾî Á¦Ç°, Ç׿°Áõ ¼Ö·ç¼Ç µî ´Ù¾çÇÑ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î Á¦¾à ºÎ¹®Àº Ç×»êÈ, Ç׿°Áõ, ¼¼Æ÷ º¸È£ ¹× Ç×¾Ï È¿°ú·Î ÀÎÇØ ÀǾàǰ¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. °Ç°»óÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í »ê¾÷ Àü¹Ý¿¡ °ÉÃÄ ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëµÇ¸é¼ »ê¾÷ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÄÍÆä·ÑÀº ¸¹Àº °úÀϰú ä¼Ò¿¡ ÇÔÀ¯µÈ õ¿¬ À¯·¡ Çö󺸳ëÀ̵å·Î °·ÂÇÑ Ç×»êÈ, Ç׿°Áõ, Ç×¾Ï ÀÛ¿ëÀ¸·Î ³ôÀº Æò°¡¸¦ ¹Þ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀÛ ¿¬µµ | 2023³â |
¿¹Ãø ¿¬µµ | 2024-2032 |
½ÃÀÛ °¡°Ý | 62¾ï ´Þ·¯ |
¿¹»ó °¡°Ý | 83¾ï ´Þ·¯ |
CAGR | 3.3% |
The Global Kaempferol Market was valued at USD 6.2 billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2032. The market growth is likely to be driven by the rising need for various pharmaceutical products, encompassing medicines, skincare items, and anti-inflammatory solutions. Globally, the pharmaceutical sector extensively utilizes kaempferol in medicines, thanks to its antioxidant, anti-inflammatory, cytoprotective, and anti-cancer properties. Heightened awareness of kaempferol's health benefits and its diverse applications across industries are propelling the industry growth. Kaempferol, a naturally occurring flavonoid in numerous fruits and vegetables, is celebrated for its robust antioxidant, anti-inflammatory, and anti-cancer properties.
The overall industry is segmented into purity, application, and region. Projected to achieve a milestone of USD 6 billion in 2023, the 98% purity segment of the market is set for notable growth, continuing at a CAGR of 3.3% from 2024 to 2032. This surge is largely due to the rising demand for high-purity kaempferol in the pharmaceutical and nutraceutical sectors, where its valued properties shine. Forecasted to reach USD 3.2 billion by 2023, the pharmaceutical application segment of the kaempferol market is set for vigorous growth, maintaining a CAGR of 3.3% from 2024 to 2032. The segment growth is fueled by the growing acknowledgment of kaempferol's therapeutic advantages. Its potent antioxidant, anti-inflammatory, and anti-cancer traits position kaempferol as a prime ingredient in crafting new drugs and treatments for diverse conditions, spanning cardiovascular diseases, diabetes, and specific cancer types.Asia Pacific kaempferol market is projected to reach a value of USD 1.6 billion in 2023. This anticipated growth is largely attributed to the rising consumer awareness regarding the health benefits of kaempferol, notably its antioxidant, anti-inflammatory, and anti-cancer attributes.
Market Scope | |
---|---|
Start Year | 2023 |
Forecast Year | 2024-2032 |
Start Value | $6.2 Billion |
Forecast Value | $8.3 Billion |
CAGR | 3.3% |